Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $38.5000 (1.85%) ($37.7000 - $39.2500) on Tue. Aug. 14, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.2% (three month average) | RSI | 48 | Latest Price | $38.5000(1.85%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 0.4% a day on average for past five trading days. | Weekly Trend | ATRA advances 0.4% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(59%) ARKG(52%) IBB(51%) IWO(50%) ARKK(49%) | Factors Impacting ATRA price | ATRA will decline at least -1.6% in a week (0% probabilities). VXX(-15%) VIXM(-14%) TLT(-14%) UUP(-12%) UNG(-5%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.6% (StdDev 3.2%) | Hourly BBV | 0 () | Intraday Trend | 1.3% | | | |
|
5 Day Moving Average | $37.75(1.99%) | 10 Day Moving Average | $37.53(2.58%) | 20 Day Moving Average | $37.97(1.4%) | To recent high | -25.2% | To recent low | 7.4% | Market Cap | $2.861b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |